Dr. Arriaga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8600- Is this information wrong?
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Henry Ford HospitalResidency, Internal Medicine, 1994 - 1997
- Cayetano Heredia UniversityClass of 1991
Certifications & Licensure
- AZ State Medical License 1997 - Present
- TX State Medical License 2006 - 2025
- PA State Medical License 2023 - 2024
- MI State Medical License 1996 - 2000
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine Start of enrollment: 2009 Mar 02
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15
Publications & Presentations
PubMed
- 8 citationsBempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V Long, Paolo A Ascierto, James Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, ...> ;Journal of Clinical Oncology. 2023 Oct 20
- 3 citationsPhase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer.Raquibul Hannan, Michael J Dohopolski, Laurentiu M Pop, Samantha Mannala, Lori Watumull, Dana Mathews, Ang Gao, Aurelie Garant, Yull E Arriaga, Isaac Bowman, Jin-Sung ...> ;Biomedicines. 2022 Jun 15
- 19 citationsDigital Health Interventions to Enhance Prevention in Primary Care: Scoping Review.Van C Willis, Kelly Jean Thomas Craig, Yalda Jabbarpour, Elisabeth L Scheufele, Yull E Arriaga, Monica Ajinkya, Kyu B Rhee, Andrew Bazemore> ;JMIR Medical Informatics. 2022 Jan 21
- Join now to see all
Journal Articles
- Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the in Vitro Integrity of T-cells from Cancer PatientsKevin Courtney, Yull Arriaga, Barbara Haley, John C Mansour, Ponciano D Cruz, David Harker, Farshid Araghizadeh, Clinical Cancer Research
Press Mentions
- What Is Melanoma?July 8th, 2021
Professional Memberships
- Member
Hospital Affiliations
- William P. Clements, Jr. University HospitalDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: